Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Other STIs”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00369824
What this trial is testing

Evaluation of Safety and Immunogenicity of Co-administering HPV Vaccine With Other Vaccines in Healthy Female Subjects

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 1,330
Large-scale testing (Phase 3)Study completedNCT00002397
What this trial is testing

Saquinavir Soft Gel Capsules (SGC) Used in Combination With Two Other Anti-HIV Drugs in Patients With HIV-Associated Kidney Disease

Who this might be right for
HIV InfectionsAIDS-Associated Nephropathy
Hoffmann-La Roche 24
Not applicableNot Yet RecruitingNCT06132672
What this trial is testing

Medical Mistrust Among Hispanic/Latino Gay, Bisexual and Other Men Who Have Sex With Men (HLMSM)

Who this might be right for
Human Immunodeficiency Virus
Wake Forest University Health Sciences 144
Not applicableStudy completedNCT00514098
What this trial is testing

Observational Study of HIV Infected Women Previously Enrolled in Other Microbicide Trials

Who this might be right for
HIV Infections
Microbicide Trials Network 479
Early research (Phase 1)UnknownNCT00006209
What this trial is testing

Tucaresol in HIV-Infected Patients Who Are Taking Other Anti-HIV Drugs

Who this might be right for
HIV Infections
Aaron Diamond AIDS Research Center 24
Not applicableStudy completedNCT00002453
What this trial is testing

A Compassionate Use Study of Tenofovir Disoproxil Fumarate as Treatment for HIV Infection

Who this might be right for
HIV Infections
Gilead Sciences 300
Testing effectiveness (Phase 2)Study completedNCT00002442
What this trial is testing

Compare the Safety and Effectiveness of Two Dosing Schedules of Lamivudine in Combination With Two Other Anti-HIV Drugs

Who this might be right for
HIV Infections
Glaxo Wellcome
Early research (Phase 1)Study completedNCT06168318
What this trial is testing

Investigate the Relative Bioavailability and Food Effect of an Oral Capsid Inhibitor Tablet Formulation Compared With Other Oral Tablet Formulations in Male and Female Healthy Participants

Who this might be right for
HIV Infections
ViiV Healthcare 46
Not applicableStudy completedNCT00002328
What this trial is testing

Azithromycin in the Treatment of Cryptosporidiosis in Patients Who Have Not Had Success With Other Drugs

Who this might be right for
CryptosporidiosisHIV Infections
Pfizer
Post-approval studies (Phase 4)Study completedNCT01422330
What this trial is testing

Evaluate the Safety, Tolerability, and Pharmacokinetics of Etravirine Administered in Combination With Other Antiretroviral Agents in Antiretroviral Treatment-Experienced HIV-1 Infected Patients

Who this might be right for
Human Immunodeficiency Virus (HIV) Infection
Janssen R&D Ireland 211
Not applicableStudy completedNCT02191293
What this trial is testing

Long-term Study in Patients Under Anti-retroviral Combination Therapy Switching to Viramune®

Who this might be right for
HIV Infections
Boehringer Ingelheim 228
Post-approval studies (Phase 4)Ended earlyNCT00100984
What this trial is testing

A 48 Week Study Comparing Treatment With Saquinavir + Lopinavir/Ritonavir in Combination With Enfuvirtide HAART Versus Saquinavir + Lopinavir/Ritonavir + Other Nucleoside Combinations to See the Efficacy of These Treatments in Patients Infected With HIV-1

Who this might be right for
HIV Infection
Hoffmann-La Roche 8
Large-scale testing (Phase 3)Study completedNCT00381303
What this trial is testing

GRACE: A Study to Compare the Effectiveness, Safety and Tolerability of PREZISTA (Darunavir)/Ritonavir by Gender and Race When Administered With Other Antiretroviral Medications in Human Immunodeficiency Virus (HIV) Positive Women and Men.

Who this might be right for
HIVInfectious
Tibotec, Inc 429
Large-scale testing (Phase 3)Study completedNCT00002368
What this trial is testing

The Safety and Effectiveness of Nevirapine Plus Lamivudine Plus Other Anti-HIV Drugs

Who this might be right for
HIV Infections
Boehringer Ingelheim 2,000
Testing effectiveness (Phase 2)Ended earlyNCT04840199
What this trial is testing

Evaluate the Anti-inflammatory Effects of Letermovir (Prevymis) in Adults With Human Immunodeficiency Virus (HIV)-1 and Asymptomatic Cytomegalovirus (CMV) Who Are on Suppressive Antiretroviral Therapy, Plus Its Effect on Chronic Inflammation, HIV Persistence and Other Clinical Outcomes.

Who this might be right for
HIV InfectionsCytomegalovirusCMV
National Institute of Allergy and Infectious Diseases (NIAID) 44
Large-scale testing (Phase 3)Study completedNCT00002382
What this trial is testing

Saquinavir Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients

Who this might be right for
HIV Infections
Hoffmann-La Roche 4,000
Testing effectiveness (Phase 2)Study completedNCT00787696
What this trial is testing

Healthy Teen Girls: HIV Risk Reduction

Who this might be right for
HIV-infection/Aids
Mississippi State University 333
Not applicableUnknownNCT00173329
What this trial is testing

The Quality of Life of Patients With Severe Illnesses

Who this might be right for
SchizophreniaHIV Infections
National Taiwan University Hospital
Not applicableLooking for participantsNCT05147519
What this trial is testing

Protocol RV 583 Multinational Observational Cohort of HIV and Other Infections

Who this might be right for
HIV Infections
Henry M. Jackson Foundation for the Advancement of Military Medicine 2,500
Testing effectiveness (Phase 2)Study completedNCT00029341
What this trial is testing

Demonstrate That Anti-HIV Drug Therapy Can be Stopped Without Causing Viral Resistance, and to Characterize Drug Elimination From the Body

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Next Page